Our Technology
From Living Models to Predictive Insights
Our proprietary HTS organoids and CLARITY platform provide human-relevant, data-driven insights to improve therapeutic development and patient outcomes.
Proprietary HTS Organoids
Human Models at Scale
At the foundation of our work are ProxyBio’s proprietary high-throughput screening (HTS) organoids. Grown directly from patient tissue, our organoids capture the complexity of human tumors and make it possible to test therapies at scale with unprecedented predictive power.
This platform is designed to reveal functional drug responses in real time — providing a level of human relevance animal models cannot match.
CLARITY
Cellular Landscape Analysis for Response Insight and TherapY
CLARITY is our extensible AI platform for analyzing organoid data at single-cell resolution. By integrating high-content imaging with advanced machine learning, CLARITY uncovers hidden subpopulations, identifies resistance pathways, and generates predictive insights that inform both drug discovery and patient treatment.
Key Capabilities
High-Content Imaging
Multi-channel, time-lapse imaging in high-throughput formats.
Single-Cell Analysis
Tracks individual cells, structures, interactions, and heterogeneity.
AI & Machine Learning
ProxyAI algorithms model responses and predict outcomes.
High-Dimensional Profiling
1,000+ features per cell for subpopulation and biomarker insights.
Bringing together the best of biology and data science
Our innovations unify patient-derived biology with advanced analytics, creating a platform that makes human models both scalable and interpretable — a foundation for more reliable discovery and development.